corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Updates

Update 2010-04-16

Updates return

This is the first Healthy Skepticism Update since September 2009. We apologise for the delay. We have been busy moving to our new website. Now that the move is almost complete we will be producing Updates about once a month.


New website

Our new website has many new features. Please see for yourself at: www.healthyskepticism.org
If you have not yet logged into the new website you will need to get your new username and password by visiting our website and clicking on:
Don’t know your username or password?
If you have any problems please contact: .(JavaScript must be enabled to view this email address)


Recent Announcements

Registration open for the Selling Sickness conference, Amsterdam Oct 7-8
Registration NOW OPEN!!
The topics - confirmed speakers - the rates - how to register - call for posters - hotel booking
Read more

T Shirts now available for sale
Healthy Skepticism T Shirts are now available for sale from Remo General Store

25 June 2010 - Prescription for Conflict: Should Industry Fund Continuing Medical Education?
A conference hosted by PharmedOut
Friday, June 25, 2010
Georgetown University Intercultural Center, Washington DC


New AdWatch issues

2010 April, USA: Wyeth’s Pristiq® (desvenlafaxine) for major depressive disorder

2009 October, USA: Amylin and Eli Lilly’s Byetta® (exenatide injection) for type 2 diabetes


Recent HS International News

March: Whose bread I eat, his song I sing
by Julian Burnside QC
Julian Burnside is a prominent Australian barrister. In 2009 he represented the lead plaintiff in a class action against Merck concerning the effects of Vioxx. This is an excerpted version of the keynote address he gave at the Royal Australian and New Zealand College of Psychiatrists Congress in Adelaide on 28 May 2009.

February: Paxil Study 329: Paroxetine vs Imipramine vs Placebo in Adolescents
by Jon Jureidini
Jon has collected a set of internal pharmaceutical company documents about study 329 that at now in the public domain following litigation.

December: Internal company documents regarding 3 atypical antipsychotic drugs
by Peter Parry and Glen Spielmans
Peter and Glen have created a set of PowerPoint files of the so called “Zyprexa documents”. These are examples of internal pharmaceutical company (in this case Eli-Lilly) documents that have been subpoenaed to court cases.

November: Big Pharma Beaten
by Steindór J. Erlingsson
GSK in Iceland forced to withdraw a drug-promoting depression booklet

 

Updates homepage

 

Comments

Our members can see and make comments on this page.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

  • E-mail
  • LinkedIn
  • Del.icio.us
  • Digg
  • Facebook
  • FriendFeed
  • Google Bookmarks
  • MySpace
  • Reddit
  • Slashdot
  • StumbleUpon
  • Tumblr
  • Twitter
  • Yahoo! Bookmarks



Next Update: Update 2010-05-18

Previous Update: Update 2009-09-20

Updates homepage






Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963